Alexion, Chugai Settle Blood Drug IP Row On Day Of Trial
AstraZeneca's Alexion Pharmaceuticals settled claims it infringed patents held by Roche-owned rival Chugai Pharmaceutical Co. on the first day of an oft-delayed trial, a Delaware court filing shows....To view the full article, register now.
Already a subscriber? Click here to view full article